HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3-methylcytidine

Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - Cytidine: 535
        3-methylcytidine: 3
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - 3-methylcytidine: 3
  - Ribonucleosides: 49
    - Cytidine: 535
      - 3-methylcytidine: 3

Experts

1.	Jeng, Long-Bin: 3 articles (01/2014 - 09/2011)
2.	Lai, Chien-Chen: 3 articles (01/2014 - 09/2011)
3.	Tsai, Fuu-Jen: 3 articles (01/2014 - 09/2011)
4.	Lin, Chiung-Tsung: 2 articles (01/2014 - 09/2011)
5.	Hsu, Wei-Yi: 2 articles (01/2013 - 09/2011)
6.	Chen, William Tzu-Liang: 1 article (01/2014)
7.	Lo, Wan-Yu: 1 article (01/2014)
8.	Chen, Chao-Jung: 1 article (01/2013)
9.	Huang, Yu-Chuen: 1 article (01/2013)
10.	Lee, Ching-Chih: 1 article (09/2011)

Related Diseases

1.	Neoplasms (Cancer) 01/20/2014 - "The mean concentrations of 5 urinary nucleosides, cytidine, 3-methylcytidine (m3C), 1-methyladenosine (m1A), adenosine, and inosine, were found to be elevated in cancer patients, but only cytidine showed a significant elevation. " 01/01/2013 - "In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. "
2.	Breast Neoplasms (Breast Cancer) 09/18/2011 - "The 3-methylcytidine may be a candidate marker for breast cancer." 09/18/2011 - "Urinary levels of 3 nucleosides, cytidine, 3-methylcytidine, and inosine were significantly higher in breast cancer patients than in normal controls (p<0.01). " 01/01/2013 - "In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. "
3.	Stomach Neoplasms (Stomach Cancer) 01/01/2013 - "In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. "
4.	Lung Neoplasms (Lung Cancer) 01/01/2013 - "In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. "
5.	Colonic Neoplasms (Colon Cancer) 01/01/2013 - "In this study, six targeted urinary nucleosides, namely adenosine, cytidine, 3-methylcytidine, 1-methyladenosine, inosine, and 2-deoxyguanosine, were chosen to evaluate their role as biomarkers of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. "

Related Drugs and Biologics

1.	Nucleosides
2.	Inosine
3.	Cytidine
4.	Adenosine (Adenocard)
5.	1-methyladenosine
6.	Biomarkers (Surrogate Marker)